HOMELAND SECURITY AFFAIRS
The Journal of the NPS Center for Homeland Defense and Security
ABSTRACT: The Anthrax Vaccine: A Dilemma for Homeland Security, May 2009
Past problems with the Department of Defense anthrax vaccine currently impact Department of Homeland Security and the Department of Health and Human Services policy. Following the 2001 anthrax letter attacks, those departments included the old anthrax vaccine in the Strategic National Stockpile. This article explores the Department of Defense’s experience with the vaccine, enumerating past safety, efficacy, regulatory, and legal problems. Public health policy alternative courses of action are suggested, including use of antibiotics and development of a new vaccine.
Center for Homeland Defense and Security 2010 Staff Article:
"Lt. Col. Thomas Rempfer’s course paper in Technology for Homeland Security may not have translated into an applicable policy or practice in the field. It did, however, expose the “silo” thinking that plagues many agencies that are tasked with homeland security responsibilities in the United States. ... Significantly, the FBI also recently finalized its findings, corroborating Rempfer’s research."
Almost a decade later, the Thesis' Conclusions / Recommendations mirror the main tenets of the United States' 2018 National Biodefense Strategy announced by the President.
Student Theses Series, Winter 2010:
The Anthrax Vaccine:
A Dilemma for Homeland Security
BY CHDS · PUBLISHED FEBRUARY 9, 2010 · UPDATED APRIL 25, 2016
Interview — video with Thomas Rempfer.
"The winner of the “Outstanding Thesis Award” for cohort 0803/0804 goes to Lt. Col. Thomas Rempfer for his in-depth study of the events leading to current policies that control the production and distribution of the Anthrax vaccine."